Mark Steven Duxon
Gründer bei Transpharmation Ltd.
Profil
Mark Steven Duxon is the founder and the Chief Executive Officer & Director of Transpharmation Ltd., a company he founded in 2010.
He is currently a Director at Vivocore, Inc.
Aktive Positionen von Mark Steven Duxon
| Unternehmen | Position | Beginn |
|---|---|---|
Transpharmation Ltd.
 Transpharmation Ltd. BiotechnologyHealth Technology Part of Vivocore, Inc., Transpharmation Ltd. is a contract research organization. The company is based in London, UK. The British company was founded in 2010 by Neil Upton, Mark Steven Duxon. Mark Steven Duxon has been the CEO since 2010. Transpharmation was acquired by Vivocore, Inc. on February 07, 2022. | Gründer | 17.08.2010 |
Vivocore, Inc.
 Vivocore, Inc. Miscellaneous Commercial ServicesCommercial Services Vivocore, Inc. is a non-invasive research and Canadian development company. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Transpharmation Ltd.
Transpharmation Ltd. BiotechnologyHealth Technology Part of Vivocore, Inc., Transpharmation Ltd. is a contract research organization. The company is based in London, UK. The British company was founded in 2010 by Neil Upton, Mark Steven Duxon. Mark Steven Duxon has been the CEO since 2010. Transpharmation was acquired by Vivocore, Inc. on February 07, 2022. | Health Technology |
Vivocore, Inc.
Vivocore, Inc. Miscellaneous Commercial ServicesCommercial Services Vivocore, Inc. is a non-invasive research and Canadian development company. | Commercial Services |
